Policies to address practices, prices, and research priorities of the pharmaceutical industry are needed. Public funding for basic research should increase, to ensure expansion of responsible and...
- There is increasing attention to preventive medicine, genetic manipulation to eliminate risks (CRISPR), lifestyle changes, etc.
- The “new patient” concept implies that patients are not only a clinical concern, but also a reflection of changes in healthcare governance — resulting in both: a health-services consumer and a socio-economically responsible person.
| Originally Published | 23 Oct 2018 |
| Knowledge service | Metadata | Foresight |The Megatrends Hub |Shifting health challenges |
| Digital Europa Thesaurus (DET) | disease preventionhealth care industrypatient safetypatient's rightspublic healthquality of lifesocial inequalitymedical research |
Goal 3 "Ensure healthy lives and promote well-being for all at all ages" of the SDGs includes two targets directly related to noncommunicable diseases.
90% of all health R&D expenditure is targeted at problems that affect only 10% of the world’s population.| Related Megatrends: Inequalities; TechnologyAbout 20% of health expenditure makes...